
Opinion|Videos|January 17, 2025
Patient Selection For Port Delivery Device
Panelists discuss how patients experiencing a high treatment burden with frequent anti-VEGF injections every 4-8 weeks are optimal candidates for the port delivery system, which can help reduce their number of clinic visits while maintaining therapeutic effectiveness.
Advertisement
Video content above is prompted by the following:
- Which patients are ideal candidates for this anti-VEGF delivery method?
- Patients with frequent anti-VEGF treatment burden (4-8 weeks)
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
FLORetina 2025: New horizons in research and risk management for ROP
2
FLORetina 2025: Remotely managing patients with neovascular age-related macular degeneration
3
FLORetina 2025: Antithrombotic use examined in wet AMD submacular hemorrhage
4
FLORetina 2025: Enrico Borrelli on reframing retinal disease through the lens of choroidal health
5













































